return to corporate website
Menu
Return to
www.noxopharm.com
Home
About Us
About Noxopharm
Management Team
Board of Directors
Scientific Advisors
Corporate Governance
Company Constitution
Sustainability
Noxopharm History
Research and Clinical Programs
Research and Clinical Programs
About Pharmorage
Investor Centre
Share Price
ASX Announcements
Why Invest in Noxopharm
Presentations & Interviews
Annual Reports
Financial Reports
Analyst Reports
Investor Fact Sheet
Investor FAQs
Upcoming Events
Privacy Policy
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
Newsletter Email Alerts
ASX Announcements Email Alerts
Investor Centre
Home
>
Investor Centre
>
ASX Announcements
Share Price
ASX Announcements
Why Invest in Noxopharm
Presentations & Interviews
Annual Reports
Financial Reports
Analyst Reports
Investor Fact Sheet
Investor FAQs
Upcoming Events
Privacy Policy
Share Registry Information
ASX Announcements
Filter by Year:
2022
2021
2020
2019
2018
2017
2016
20-Dec-2016
Change in substantial holding
20-Dec-2016
Change of Director's Interest Notice - ID
20-Dec-2016
Change of Director's Interest Notice - GK
20-Dec-2016
Market Capitalisation - further update
20-Dec-2016
Appendix 3B
19-Dec-2016
Market Capitalisation Update
23-Nov-2016
Results of Meeting
23-Nov-2016
Breakthrough in Delivering Idronoxil into Brain
22-Nov-2016
Corporate Presentation Updated
22-Nov-2016
Corporate Presentation Providing Clinical Program Guidance
1
2
3
4
5
Next
